Andrea Gaedigk

20.5k total citations · 12 hit papers
237 papers, 13.7k citations indexed

About

Andrea Gaedigk is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Andrea Gaedigk has authored 237 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Pharmacology, 58 papers in Pediatrics, Perinatology and Child Health and 57 papers in Oncology. Recurrent topics in Andrea Gaedigk's work include Pharmacogenetics and Drug Metabolism (165 papers), Drug Transport and Resistance Mechanisms (50 papers) and Pharmaceutical studies and practices (43 papers). Andrea Gaedigk is often cited by papers focused on Pharmacogenetics and Drug Metabolism (165 papers), Drug Transport and Resistance Mechanisms (50 papers) and Pharmaceutical studies and practices (43 papers). Andrea Gaedigk collaborates with scholars based in United States, Canada and Spain. Andrea Gaedigk's co-authors include J. Steven Leeder, Teri E. Klein, Katrin Sangkuhl, Michelle Whirl‐Carrillo, JS Leeder, L. DiAnne Bradford, Stuart A. Scott, Kelly E. Caudle, Roger Gaedigk and Todd C. Skaar and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Andrea Gaedigk

231 papers receiving 13.4k citations

Hit Papers

Clinical Pharmacogenetics... 2007 2026 2013 2019 2015 2007 2014 2016 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
    2015 672 citations Katrin Sangkuhl, Adrián LLerena et al. Clinical Pharmacology & Therapeutics profile →
  2. The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
    2007 587 citations Andrea Gaedigk et al. Clinical Pharmacology & Therapeutics profile →
  3. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
    2014 453 citations Andrea Gaedigk, Henry M. Dunnenberger et al. Clinical Pharmacology & Therapeutics profile →
  4. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
    2016 450 citations Katrin Sangkuhl, Kazutaka Shimoda et al. Clinical Pharmacology & Therapeutics profile →
  5. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
    2019 369 citations Kelly E. Caudle, Katrin Sangkuhl et al. Clinical and Translational Science profile →
  6. Prediction of CYP2D6 phenotype from genotype across world populations
    2016 352 citations Andrea Gaedigk, Katrin Sangkuhl et al. profile →
  7. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
    2017 294 citations Andrea Gaedigk, Neil Miller et al. Clinical Pharmacology & Therapeutics profile →
  8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
    2018 237 citations Katrin Sangkuhl, Henk‐Jan Guchelaar et al. Clinical Pharmacology & Therapeutics profile →
  9. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
    2020 208 citations Kelly E. Caudle, Andrea Gaedigk et al. Clinical Pharmacology & Therapeutics profile →
  10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
    2020 194 citations Zeruesenay Desta, Larisa H. Cavallari et al. Clinical Pharmacology & Therapeutics profile →
  11. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
    2023 181 citations Laura B. Ramsey, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics profile →
  12. PharmVar GeneFocus: CYP2B6
    2021 178 citations Zeruesenay Desta, Andrew A. Somogyi et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Gaedigk United States 60 8.9k 3.6k 3.0k 2.7k 2.1k 237 13.7k
J. Steven Leeder United States 58 5.1k 0.6× 4.2k 1.2× 2.6k 0.9× 2.3k 0.9× 2.1k 1.0× 248 13.3k
Ann K. Daly United Kingdom 74 9.9k 1.1× 2.3k 0.7× 4.5k 1.5× 4.3k 1.6× 1.9k 0.9× 282 20.5k
Kenneth E. Thummel United States 73 11.5k 1.3× 4.7k 1.3× 7.2k 2.4× 3.1k 1.2× 1.8k 0.9× 263 20.2k
Ulrich M. Zanger Germany 74 10.1k 1.1× 3.1k 0.9× 6.8k 2.3× 5.1k 1.9× 1.7k 0.8× 197 19.8k
Jürgen Brockmöller Germany 65 5.1k 0.6× 2.7k 0.7× 4.0k 1.3× 4.0k 1.5× 1.6k 0.7× 236 13.8k
Michelle Whirl‐Carrillo United States 45 5.3k 0.6× 2.2k 0.6× 1.5k 0.5× 2.4k 0.9× 1.3k 0.6× 103 9.3k
Ivar Roots Germany 68 5.9k 0.7× 3.3k 0.9× 4.9k 1.7× 4.7k 1.7× 1.8k 0.8× 253 16.4k
Paul B. Watkins United States 73 11.5k 1.3× 3.2k 0.9× 6.2k 2.1× 3.5k 1.3× 2.2k 1.0× 246 19.9k
David A. Flockhart United States 63 5.6k 0.6× 1.3k 0.4× 4.3k 1.4× 3.9k 1.4× 1.9k 0.9× 255 15.3k
Amin Rostami‐Hodjegan United Kingdom 71 6.5k 0.7× 3.7k 1.0× 4.9k 1.6× 2.7k 1.0× 2.1k 1.0× 324 16.0k

Countries citing papers authored by Andrea Gaedigk

Since Specialization
Citations

This map shows the geographic impact of Andrea Gaedigk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Gaedigk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Gaedigk more than expected).

Fields of papers citing papers by Andrea Gaedigk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Gaedigk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Gaedigk. The network helps show where Andrea Gaedigk may publish in the future.

Co-authorship network of co-authors of Andrea Gaedigk

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Gaedigk. A scholar is included among the top collaborators of Andrea Gaedigk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Gaedigk. Andrea Gaedigk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaedigk, Andrea, et al.. (2025). Long‐Read Sequencing Enhances Pharmacogenomic Profiling by Resolving Complex Haplotypes, Novel Star Alleles, and Structural Variants. Clinical Pharmacology & Therapeutics. 119(2). 536–545.
2.
Eadon, Michael T., David W. Hein, Michael Asger Andersen, et al.. (2025). Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clinical Pharmacology & Therapeutics. 118(6). 1430–1436.
3.
Eum, Seenae, Zeruesenay Desta, Rachel F. Tyndale, et al.. (2024). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical Pharmacology & Therapeutics. 116(4). 932–938. 9 indexed citations
4.
Pratt, Victoria M., Larisa H. Cavallari, Andrea Gaedigk, et al.. (2024). DPYD Genotyping Recommendations. Journal of Molecular Diagnostics. 26(10). 851–863. 21 indexed citations
5.
Gaedigk, Andrea, Susan M. Abdel‐Rahman, Vincent S. Staggs, et al.. (2024). Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children. Clinical and Translational Science. 17(4). e13782–e13782. 2 indexed citations
6.
Zubiaur, Pablo, Erin C. Boone, Jean Dinh, et al.. (2023). Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity. Clinical Pharmacology & Therapeutics. 114(5). 1033–1042. 9 indexed citations
7.
Gaedigk, Andrea, Erin C. Boone, Amy Turner, et al.. (2023). Characterization of Reference Materials for CYP3A4 and CYP3A5. Journal of Molecular Diagnostics. 25(9). 655–664. 8 indexed citations
8.
Ramsey, Laura B., et al.. (2023). Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens. Clinical Pharmacology & Therapeutics. 114(1). 69–76. 14 indexed citations
9.
Cramer, Estee Y., Jacquelaine Bartlett, E. Ricky Chan, et al.. (2023). Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism. Pharmacogenomics. 24(11). 583–597.
10.
García‐Berrocal, Belén, et al.. (2022). Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy. Pharmaceutics. 14(1). 160–160. 2 indexed citations
11.
Chan, E. Ricky, Rajeev K. Mehlotra, Arsène Ratsimbasoa, et al.. (2022). CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study. Pharmacogenomics. 23(5). 315–325. 2 indexed citations
12.
Pratt, Victoria M., Amy Turner, Ulrich Broeckel, et al.. (2021). Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX. Journal of Molecular Diagnostics. 23(8). 952–958. 11 indexed citations
13.
Gaedigk, Andrea, Ekawat Pasomsub, Wasun Chantratita, et al.. (2020). Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Tangwongchai, Sookjaroen, et al.. (2020). CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Paul, Jeffrey, et al.. (2018). Impact of CYP2D6 on Venlafaxine Metabolism in Trinidadian Patients with Major Depressive Disorder. Pharmacogenomics. 19(3). 197–212. 5 indexed citations
16.
Yang, Jun J., Michelle Whirl‐Carrillo, Stuart A. Scott, et al.. (2018). Pharmacogene Variation Consortium Gene Introduction: NUDT15. Clinical Pharmacology & Therapeutics. 105(5). 1091–1094. 40 indexed citations
17.
Hicks, J. Kevin, Katrin Sangkuhl, Jesse J. Swen, et al.. (2017). Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Data Archiving and Networked Services (DANS). 57 indexed citations
18.
19.
Bishop, Jeffrey R., Katrin Sangkuhl, Daniel J. Müller, et al.. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. PMC. 51 indexed citations
20.
Findling, Robert L., Gianluca Nucci, Antoni A Piergies, et al.. (2005). Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder. Neuropsychopharmacology. 31(6). 1274–1285. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Steven Leeder Breakdown of academic impact, for papers by Ann K. Daly Breakdown of academic impact, for papers by Kenneth E. Thummel Breakdown of academic impact, for papers by Ulrich M. Zanger Breakdown of academic impact, for papers by Jürgen Brockmöller Breakdown of academic impact, for papers by Michelle Whirl‐Carrillo Breakdown of academic impact, for papers by Ivar Roots Breakdown of academic impact, for papers by Paul B. Watkins Breakdown of academic impact, for papers by David A. Flockhart Breakdown of academic impact, for papers by Amin Rostami‐Hodjegan
Rankless by CCL
2026